Visit https://www.peervoice.com/UJN860 to view the entire programme with slides. After completing “Putting Renal Protection at the Heart of Type 2 Diabetes Management in Primary Care”, participants will be able to: Recognize the relationship between kidney disease, T2DM, cardiovascular risks, and the importance of screening; Discuss the clinical evidence, with the focus on renal outcomes, with SGLT2 inhibitors in patients with T2DM; and Evaluate the role of SGLT2 inhibitors in improving renal and cardiovascular health in patients with T2DM treated in primary care.